Kowa Pharmaceuticals America 2025-03-19 Health moderate FDA
Health · FDA · Recall #FDA-D-0258-2025
Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by:… Recall
Issued March 19, 2025 · Kowa Pharmaceuticals America
In March 2025, Kowa Pharmaceuticals America recalled the Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by:…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Presence of foreign tablets/capsules
What you should do
- 1 Stop using Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by:… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Kowa Pharmaceuticals America to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Kowa Pharmaceuticals America
- Category
- Health
- Recall date
- March 19, 2025
- Units affected
- Not reported
- Sold at
- PA, OH, and TX
- Recall number
- FDA-D-0258-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Kowa Pharmaceuticals America has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.